Do you know pheo and para? Chances are, the answer to that question is no. After all, fewer than eight out of one million people are diagnosed with pheo (pheochromocytoma) and para (paraganglioma) per year. But, if you are one of those eight people, or a doctor who is new to the disease, the information found on KnowPheoPara.health could save your life, or the life of someone else.
Bayer G4A is a global program formerly known as Grants4Apps. These days, the “A” in G4A stands for much more — acceleration, advancement, AI, and everything else that’s advancing the current state of digital health. Officially, G4A is a global program within Bayer that “supports startups and companies that are developing innovative solutions in health and care.” In other words, Bayer is tapping into the entrepreneurial ecosystem to facilitate progress — both within its own ranks, and within the healthcare and wellness industries as a whole.
This past week, I headed up to Philly with our CEO Jose Ignacio Rasco. We were proud to sponsor the eyeforpharma Philadelphia conference and lead a discussion for some of the world’s most talented pharmaceutical marketing executives on “What’s in a Name?” – why the name (and the domain name) you choose matters.